Zobrazeno 1 - 10
of 1 154
pro vyhledávání: '"M, Neidhart"'
Publikováno v:
Expanding Underground-Knowledge and Passion to Make a Positive Impact on the World ISBN: 9781003348030
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad19a2287c84fce5fbe90202d7741108
https://doi.org/10.1201/9781003348030-347
https://doi.org/10.1201/9781003348030-347
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kimberly Brewer, Jacob Joseph Machin, George Maylin, Clara Fenger, Abelardo Morales‐Briceño, Martina M. Neidhart, Thomas Tobin
Publikováno v:
Drug Testing and Analysis. 14:774-780
Autor:
George C. Schatz, Teri W. Odom, Abhishek K. Amrithanath, Young-Ah Lucy Lee, Sridhar Krishnaswamy, Zeynab Mousavikhamene, Suzanne M. Neidhart
Publikováno v:
Small (Weinheim an der Bergstrasse, Germany). 18(1)
This paper describes a self-regulating system that combines wrinkle-patterned hydrogels with plasmonic nanoparticle (NP) lattices. In the feedback loop, the wrinkle patterns flatten in response to moisture, which then allows light to reach the NP lat
Autor:
Céleste Lebbé, S. Dalle, A. Blom, Nora Kramkimel, Bernard Cribier, A. Seris, L. Mortier, Ouidad Zehou, Sophie Dalac, Marisa Battistella, A. Dupuy, réseau de cancers rares dermatologiques Pour Caraderm, Marie-Laure Jullie, E.-M. Neidhart-Berard, Marie Beylot-Barry, Thomas Jouary
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 146:704-710
Resume Introduction CARADERM (CARcinomes RAres en DERMatologie) est un projet national d’enregistrement et de suivi des cancers cutanes rares, labellise par l’INCa (Institut national du Cancer) depuis 2014. Cet article presente le reseau CARADERM
Publikováno v:
The Journal of Physical Chemistry C. 122:1430-1436
Molecular dynamics simulations were performed to model the interfacial thermal conductance (G) from bare gold nanoparticles (icosahedral, cuboctahedral, and spherical) to a hexane solvent. The computed conductance was found to depend not only on part
Autor:
A, Seris, M, Battistella, M, Beylot-Barry, S, Dalle, L, Mortier, C, Lebbé, A, Blom, E-M, Neidhart-Berard, N, Kramkimel, A, Dupuy, O, Zehou, S, Dalac, M-L, Jullie, B, Cribier, T, Jouary
Publikováno v:
Annales de dermatologie et de venereologie. 146(11)
CARADERM is a French national network that includes patients with rare skin adnexal neoplasms. The present paper describes only the adnexal neoplasm part of this network. The primary objective of CARADERM is to improve medical care for malignant skin
Autor:
L. A. Cerezo, M. Remakova, M. Tom ik, S. Gay, M. Neidhart, E. Lukanidin, K. Pavelka, M. Grigorian, J. Vencovsky, L. enolt
Publikováno v:
Rheumatology. 53:1520-1526
Objectives. S100A4 has been implicated in cancer and several inflammatory diseases, including RA. The aim of the present study was to determine whether S100A4 can stimulate proinflammatory cytokine production in mononuclear cells. Methods. Peripheral
Autor:
Thierry Lesimple, Natacha Heutte, Antoine Thyss, Florence Joly, C. Delcambre, E. M. Neidhart-Berard, Frédéric Mouriaux, L. Peyro Saint Paul, C. Dutriaux, A. D. Pham, Vincent Servois, Nicolas Penel, Jean-Jacques Parienti, S. Piperno-Neumann
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2016, 115 (1), pp.20-4. ⟨10.1038/bjc.2016.119⟩
British Journal of Cancer, 2016, 115 (1), pp.20-4. ⟨10.1038/bjc.2016.119⟩
British Journal of Cancer, Cancer Research UK, 2016, 115 (1), pp.20--24. ⟨10.1038/bjc.2016.119⟩
British Journal of Cancer, Cancer Research UK, 2016, 115 (1), pp.20-24. ⟨10.1038/bjc.2016.119⟩
British Journal of Cancer, Cancer Research UK, 2016, 115 (1), pp.20-4. ⟨10.1038/bjc.2016.119⟩
British Journal of Cancer, 2016, 115 (1), pp.20-4. ⟨10.1038/bjc.2016.119⟩
British Journal of Cancer, Cancer Research UK, 2016, 115 (1), pp.20--24. ⟨10.1038/bjc.2016.119⟩
British Journal of Cancer, Cancer Research UK, 2016, 115 (1), pp.20-24. ⟨10.1038/bjc.2016.119⟩
International audience; Background: The aim of the study was to analyse efficacy, safety, and health-related quality of life (HRQoL) for sorafenib treatment in patients with metastatic uveal melanoma. Methods: A multicentre, single-arm phase II trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3041cb555abb28a5410d6d01e673db91
https://hal.archives-ouvertes.fr/hal-01576007
https://hal.archives-ouvertes.fr/hal-01576007
Autor:
L. Andres Cerezo, K. Kuncova, H. Mann, M. Tomcik, J. Zamecnik, E. Lukanidin, M. Neidhart, S. Gay, M. Grigorian, J. Vencovsky, L. Senolt
Publikováno v:
Rheumatology. 50:1766-1772
Objectives. The S100A4 protein is known as a metastasis promoting factor; however, its involvement in non-malignant diseases such as RA and psoriasis has been recently described. The aim of this study was to investigate the expression and possible ro